We recently produced an HSA-Trx fusion protein that has long acting anti-oxidative activity and has superior preventing effects to NAC, a typical anti-oxidant, in drug-induced AKI, such as experimental contrast-induced nephropathy or cisplatin-induced nephropahy mouse models19, 20. The gene discussed is TXN; the disease is Nephropathy.